RVTY - Revvity Inc.
Close
122.54
0.360 0.294%
Share volume: 786,607
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$122.18
0.36
0.30%
View ratios
Fiscal Date | 2022-07-03 | 2022-10-02 | 2023-01-01 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-09 | 2022-11-14 | 2023-03-01 | 2023-05-12 | 2023-08-09 | 2023-11-07 | 2024-02-27 | 2024-05-07 | |
Assets | |||||||||
Total Assets | 14.190 B | 13.824 B | 14.130 B | 14.638 B | 14.219 B | 13.422 B | 13.565 B | 13.433 B | |
Current Assets | 2.108 B | 3.116 B | 3.289 B | 3.796 B | 3.523 B | 2.913 B | 3.001 B | 3.059 B | |
Inventories | 624.297 M | 378.256 M | 405.462 M | 429.423 M | 436.822 M | 435.696 M | 428.062 M | 414.029 M | |
Other Current Assets | 190.484 M | 138.867 M | 122.254 M | 318.116 M | 388.626 M | 403.275 M | 337.139 M | 360.929 M | |
Short Term Investments | 190.484 M | 138.867 M | 122.254 M | 318.116 M | 388.626 M | 403.275 M | 337.139 M | 360.929 M | |
Total Receivables | 932.131 M | 540.867 M | 612.780 M | 586.922 M | 626.935 M | 644.574 M | 632.811 M | 588.974 M | |
Current Cash | 360.860 M | 400.741 M | 454.358 M | 2.461 B | 2.071 B | 1.430 B | 1.603 B | 1.695 B | |
Total Non-current Assets | 12.082 B | 10.707 B | 10.841 B | 10.843 B | 10.695 B | 10.508 B | 10.564 B | 10.373 B | |
Property Plant Equipment | 533.645 M | 460.397 M | 482.950 M | 491.162 M | 490.923 M | 489.747 M | 509.654 M | 503.964 M | |
Other Assets | 324.245 M | 312.297 M | 256.551 M | 382.868 M | 321.568 M | 307.029 M | 285.760 M | 297.635 M | |
Intangible Assets | 3.771 B | 3.401 B | 3.377 B | 3.295 B | 3.197 B | 3.085 B | 3.022 B | 2.919 B | |
Goodwill | 7.243 B | 6.373 B | 6.482 B | 6.506 B | 6.518 B | 6.470 B | 6.534 B | 6.504 B | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 14.190 B | 13.824 B | 14.130 B | 14.638 B | 14.219 B | 13.422 B | 13.565 B | 13.433 B | |
Total liabilities | 7.023 B | 6.759 B | 6.747 B | 6.604 B | 6.349 B | 5.727 B | 5.692 B | 5.586 B | |
Total current liabilities | 1.044 B | 1.486 B | 1.544 B | 1.564 B | 1.367 B | 1.448 B | 1.450 B | 1.374 B | |
Accounts Payable | 333.711 M | 275.824 M | 272.826 M | 266.884 M | 235.721 M | 188.302 M | 204.121 M | 183.532 M | |
Other liabilities | 1.311 B | 1.232 B | 1.109 B | 1.010 B | 953.838 M | 993.046 M | 930.946 M | 919.795 M | |
Current long term debt | 4.180 M | 503.549 M | 470.929 M | 479.423 M | 478.936 M | 727.539 M | 721.872 M | 711.443 M | |
Long term debt | 4.484 B | 3.898 B | 3.923 B | 3.881 B | 3.884 B | 3.152 B | 3.178 B | 3.165 B | |
Other liabilities | 1.311 B | 1.232 B | 1.109 B | 1.010 B | 953.838 M | 993.046 M | 930.946 M | 919.795 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 7.167 B | 7.065 B | 7.383 B | 8.034 B | 7.870 B | 7.694 B | 7.873 B | 7.846 B | |
Common stock | 126.126 M | 126.155 M | 126.202 M | 126.285 M | 125.215 M | 123.992 M | 123.324 M | 123.428 M | |
Retained earnings | 4.757 B | 4.834 B | 4.951 B | 5.512 B | 5.539 B | 5.539 B | 5.609 B | 5.627 B |